RecruitingNot ApplicableNCT06545760

Admission to Kangaroo Mother Care (KMC) Ward and Maternal Postpartum Depression

Admission to the Kangaroo Mother Care Ward and Maternal Postpartum Depression: A Randomized Controlled Trial


Sponsor

University of Alabama at Birmingham

Enrollment

1,908 participants

Start Date

Dec 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if extended admission to the Kangaroo Mother Care (KMC) ward helps to prevent postpartum depression in mothers of low birthweight infants in a low-resource setting whose newborns were admitted to the neonatal intensive care unit (NICU) more than standard of care KMC. The main questions it aims to answer are: * Does longer KMC decrease the incidence of postpartum depression in mothers of low birthweight infants in a low-resource setting? * Does longer KMC improve neurodevelopmental outcomes of low birthweight infants at 6, 12, and 18 months in a low-resource setting? * What are the barriers to practicing KMC in low birthweight infants following hospital discharge in a low-resource setting? * What is the prevalence of paternal depression in a low resource setting? * Is it cost effective to admit preterm mother-infant dyads to the KMC ward following NICU discharge? Researchers will compare (extended admission to the KMC ward) to (standard of care KMC) to see if extended KMC decreases PPD in mothers of preterm infants in low-resource settings. Participants (infants) will: * At time of discharge from the NICU, when clinically stable, spend either \< 2 days in the KMC ward with their mothers or spend longer in the KMC ward until discharge. * Return to clinic at routine follow-up visits (at 2 weeks and at 6-8 weeks) where mothers will be screened for postpartum depression and fathers will be screened for depression. * Return to clinic for neurodevelopmental screening at 6, 12, and 18 months where mothers will be screened for postpartum depression and perceived social support and fathers will be screened for depression.


Eligibility

Min Age: 1 DayMax Age: 89 Years

Inclusion Criteria11

  • AIM #1-2 and #5
  • Mothers to newborns who are:
  • \) Birthweight between 1000-2000gm 2) Admitted to the Women and Neonates Hospital-University Teaching Hospital Neonatal Intensive Care Unit (WNH-UTH NICU) (\>48hrs) 3) Stable preterm eligible for continuing kangaroo mother care (KMC) in the NICU or NICU discharge 4) 16+ years of age (Mother) 5) Residing within Lusaka Province with no intensions to relocate in the coming 18 months
  • AIM #3
  • Parents (mothers and fathers) whose newborn has been enrolled in the study
  • Trusted family member or friend of the mother whose newborns is enrolled into the study
  • + years of age (mothers and fathers)
  • + years of age (family members)
  • AIM # 4:
  • Fathers whose newborn has been enrolled into the study
  • + years of age (father)

Exclusion Criteria10

  • AIM #1-2 and #5
  • Mothers who are on treatment for depression and/or anxiety
  • Mothers who did not consent
  • Underage mothers (16-17 years of age) whose parent(s) has not provided consent for their participation in the study
  • AIM #3
  • \) Family members of parents who do not consent to study participation
  • AIM # 4:
  • Fathers who are on treatment for depression and/or anxiety
  • Fathers who did not provide informed consent
  • Underage fathers (16-17 years of age) whose parent(s) has not provided consent for their participation in the study

Interventions

BEHAVIORALKangaroo mother care (KMC) support for > 2 days

Admission to the kangaroo mother care (KMC) ward with continued support of kangaroo mother care, breastfeeding, and preterm infant care for greater than 2 days prior to discharge home

BEHAVIORALKangaroo mother care (KMC) support for < 2 days

Admission to the kangaroo mother care (KMC) ward with continued support of kangaroo mother care, breastfeeding, and preterm infant care for less than 2 days prior to discharge home


Locations(1)

Women and Newborn Hospital - University Teaching Hospitals

Lusaka, Zambia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06545760


Related Trials